PARK CITY, Utah, April 1, 2021 /PRNewswire/ — Funding and progress agency Valkyrie Group (“Valkyrie”) has dedicated an funding of $25 million into Aneira Pharma, Inc. (“Aneira”) for use towards completion of its scientific trials. Aneira is growing a ground-breaking, prescription-based hair progress product for women and men experiencing hair loss. Valkyrie’s resolution to take a position is the results of their expertise with Aneira’s founders and their profitable backgrounds in constructing innovating merchandise. It additionally meets Valkyrie’s dedication to funding easy enterprise funding methods.
Chad Swensen, Founder and Managing Companion of Valkyrie, famous, “The untapped demand potential for a product like Aneira’s is critical, significantly as we perceive that the worldwide hair loss market will proceed to develop and is anticipated to exceed $12 billion within the subsequent few years.”
Valkyrie co-founding associate and former Goldman Sachs international investor Mark McGoldrick agrees. “This product could be a game-changer providing within the multi-billion-dollar hair progress market which as we speak provides restricted cures for hair loss. Our partnership with Aneira permits us to play an integral function with this thrilling firm and undertake an easy funding technique in an trade with an annual compounded progress charge that exceeds 5%.”
The Aneira product presently in growth, guarantees to supply outcomes of newer, thicker and darker hair progress with out undesirable unwanted side effects. When accepted, the hair progress product can be Aneira’s first product to market, though not the one product of their pipeline. The Firm has plans for added hair progress merchandise for the underserved, however massive markets. These embody merchandise being developed to regrow hair for sufferers which have misplaced hair resulting from sickness and/or hair loss issues. Moreover, Aneira is growing a formulation for eyebrow progress and eyebrow thickening.
Aneira was based by veteran biotech/pharmaceutical executives with a variety of experience. Co-founders John Wurst and Kenton Abel, Ph.D., are patent attorneys who’ve expertise with each start-up and established biotech/pharmaceutical corporations. Wurst served as lead patent lawyer for LatisseÆ and different hair progress merchandise earlier than co-founding Aneira.
“We’re happy to have Valkyrie as our capital associate,” Wurst mentioned. “Valkyrie’s intensive background and workforce give us the required capital and expertise to assist drive the expansive short-term and long-term progress of the corporate.”
Abel previously oversaw the patent portfolio and technique for Botox® and was a co-founder of Bonti, Inc., an organization acquired by Allergan for $195 million.
About Aneira Pharma, Inc. (https://www.aneirapharma.com)
Aneira Pharma, Inc. is a San Diego-based startup with a mission to create a brand new technology of hair progress merchandise by a wedding of the perfect science, individuals, and know-how.
About Valkyrie Group (https://valkyriegrp.com)
Valkyrie Group, with workplaces in Newport Seaside, California, and Park Metropolis, Utah, is a growth-driven funding platform targeted on constructing the appropriate groups and establishing early distribution and different value-added partnerships. Valkyrie Group’s funding in Aneira is one in every of a number of investments in its portfolio.
Doug Corpuz – Vice President Operations, Valkyrie Group LLC
e mail: [email protected]
SOURCE Valkyrie Group LLC